Efficacy and safety of percutaneous coronary intervention in acute coronary syndrome patients randomized to enoxaparin or unfractionated heparin: Results of SYNERGY

被引：0
|
作者：
White, HD
Kleiman, NS
Chew, D
Petersen, JL
Berdan, LG
Traylor, L
Mahaffey, KW
Cohen, M
Santos, R
Harrington, RA
Califf, RM
Ferguson, JJ
机构：
[1] Green Lane Hosp, Auckland 3, New Zealand
[2] Duke Univ, Clin Res Inst, Durham, NC USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2005年 / 45卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：61A / 61A
页数：1
相关论文
共 50 条
  • [21] Intravenous Enoxaparin Or Unfractionated Heparin In Primary Percutaneous Coronary Intervention Of St Elevation Myocardial Infarction
    Collet, Jean-Philippe
    Landivier, Antoine
    Vignolles, Nicolas
    Beygui, Farzin
    Barthelemy, Olivier
    Silvain, Johanne
    Choussat, Reimi
    Pena, Ana
    Montalescot, Gilles
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 50I - 50I
  • [22] Enoxaparin Versus Unfractionated Heparin on Bleeding and Cardiac Events in Korean Patients Undergoing Elective Percutaneous Coronary Intervention
    Ha, Sang Jin
    Kim, Hyun Soo
    Woo, Jong Shin
    Kim, Woo-Shik
    Kim, Soo Joong
    Kim, Kwon Sam
    Kim, Weon
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (07): : 91B - 91B
  • [23] Does Enoxaparin Have Enough FINESSE to Replace Unfractionated Heparin in Primary Percutaneous Coronary Intervention?
    Goodman, Shaun G.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (02) : 213 - 214
  • [24] Efficacy and safety of fondaparinux versus Enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Results from the OASIS-5 trial
    Mehta, Shamir R.
    Granger, Christopher B.
    Eikelboom, John W.
    Bassand, Jean-Pierre
    Wallentin, Lars
    Faxon, David P.
    Peters, Ron J. G.
    Budaj, Andrzej
    Afzal, Rizwan
    Chrolavicius, Susan
    Fox, Keith A. A.
    Yusuf, Salim
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (18) : 1742 - 1751
  • [25] Efficacy of Cilostazol in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention
    Hu, Taohong
    Ma, Huili
    Li, Huijun
    Ren, Jianghua
    AMERICAN JOURNAL OF THERAPEUTICS, 2013, 20 (02) : 151 - 153
  • [26] Unfractionated versus fractionated heparin for percutaneous coronary intervention
    Arjomand H.
    Surabhi S.K.
    Cohen M.
    Current Cardiology Reports, 2002, 4 (4) : 327 - 333
  • [27] Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis
    Murphy, Sabina A.
    Gibson, Charles Michael
    Morrow, David A.
    De Werf, Frans Van
    Menown, Ian B.
    Goodman, Shaun G.
    Mahaffey, Kenneth W.
    Cohen, Marc
    McCabe, Carolyn H.
    Antman, Elliott M.
    Braunwald, Eugene
    EUROPEAN HEART JOURNAL, 2007, 28 (17) : 2077 - 2086
  • [28] Comparative effectiveness and costs of enoxaparin versus unfractionated heparin in treating acute coronary syndrome
    Xiao, Z. M.
    Rosenthal, N.
    Kartashov, A.
    Levorsen, A.
    Shah, B.
    EUROPEAN HEART JOURNAL, 2019, 40 : 4025 - 4025
  • [29] Heparin or Enoxaparin Anticoagulation for Primary Percutaneous Coronary Intervention
    Brieger, David
    Collet, Jean-Philippe
    Silvain, Johanne
    Landivier, Antoine
    Barthelemy, Olivier
    Beygui, Farzin
    Bellemain-Appaix, Anne
    Mercadier, Anne
    Choussat, Remi
    Vignolles, Nicolas
    Costagliola, Dominique
    Montalescot, Gilles
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2011, 77 (02) : 182 - 190
  • [30] Enoxaparin versus unfractionated heparin: Consequences of treatment duration on efficacy and safety in SYNERGY
    Ferguson, JJ
    Mahaffey, KW
    Huang, Y
    Armstrong, P
    Levine, G
    Kleiman, NS
    Goodman, SG
    Cohen, M
    Antman, E
    Califf, RM
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 247A - 248A
12345